shionogi

Press Release (2010)

News Release Backnumber
2010/09/01 Dissolution of a Subsidiary
2010/08/02 Financial Results for the First Quarter of Fiscal Year 2010
2010/07/23 Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference
2010/07/21 Shionogi-ViiV Healthcare Announces Commitment to Phase III Development Programme for Investigational Once-Daily HIV Integrase Inhibitor
2010/07/01 Shionogi announces reorganization of US Operations, new leadership.
2010/06/30 CRESTOR® PATENT UPHELD BY US DISTRICT COURT, DISTRICT OF DELAWARE
2010/06/17 Establishment of an Organization
2010/06/01 Shionogi Announces the Conducting of Drug Discovery Competition FINDS2010 -Drug seeds fostering type-
2010/05/10 Shionogi Establishes Shionogi Techno Advance Research Co., Ltd.
2010/05/10 New Quinolone Oral Antibiotic Avelox®: Sales Rights Transfer
2010/04/27 Shionogi Appeals Patent Infringement lawsuit for Flomox® (Oral cephem antibiotic agent) to the Intellectual Property High Court
2010/04/16 Launch of an Antidepressant Drug,"Cymbalta® Capsules 20mg and 30mg"
2010/03/16 SHIONOGI'S THIRD MEDIUM-TERM BUSINESS PLAN
2010/03/11 Shionogi and TAKATA SEIYAKU Announce Agreement on Succession of Marketing and Manufacturing Rights
2010/03/02 SHIONOGI ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH QUATRX PHARMACEUTICALS TO MARKET OSPEMIFENE
2010/02/22 NOTIFICATION OF SUBSIDIARY TRANSFER
2010/02/22 Shionogi Announces Appointment of Directors, Corporate Officers and Corporate Reorganization
2010/02/15 Shionogi Files an Additional Application for Pediatric Use of "RAPIACTA®" a Novel Anti-viral Drug for Influenza
2010/02/01 Financial Results for the Third Quarter of Fiscal Year 2009
2010/01/26 A Novel Anti-viral Drug for Influenza,"RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion" Launch
2010/01/25 Shionogi Supports Relief Efforts for Haiti Earthquake Victims
2010/01/20 Shionogi Receives Marketing and Manufacturing Approval of an Antidepressant Drug,"Cymbalta ®Capsules 20mg and 30mg"
2010/01/13 Shionogi Receives Marketing and Manufacturing Approval of a Novel Anti-viral Drug for Influenza, "RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion"
2010/01/12 SCIELE PHARMA, INC., A SHIONOGI GROUP COMPANY, ANNOUNCES NAME CHANGE



page top